Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
- Status
- COMPLETED
- Phase
- NA
Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
- Status
- COMPLETED
- Phase
- PHASE1
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Triple Negative Breast Cancer Trial
- Status
- UNKNOWN
- Phase
- PHASE3
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
- Status
- TERMINATED
- Phase
- PHASE2
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
- Status
- UNKNOWN
- Phase
- NA
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
- Status
- TERMINATED
- Phase
- PHASE3
Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1